Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
|
|
CENTRUE FINANCIAL CORP (CFCB)
|
Add to portfolio |
|
|
|
| Price: |
$27.73
| | Metrics |
| OS: |
6.51
|
M
| |
5
|
% ROE
|
| Market cap: |
$181
|
M
| |
|
|
|
|
|
| |
|
|
|
|
|
| | | |
| | | | | |
| TTM Valuation | | | |
|
|
|
| |
|
|
|
|
|
| |
|
|
| EPS |
$1.57
| |
17.7
|
x P/E
|
|
BVPS
|
$19.71
| |
1.41
|
x P/B
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-11 | Dec-31-10 | Dec-31-09 | Dec-31-08 |
| Revenues | 41.4 | 38.4 | 29.7 | | 28.5 | 6.7 | -30.0 | 43.1 |
| Revenue growth | 8.0% | 29.1% | | | 322.4% | -122.5% | -169.5% | -14.0% |
| Cost of goods sold | 19.4 | 19.6 | 18.4 | | 17.0 | 17.7 | 19.6 | 17.6 |
| Gross profit | 22.0 | 18.7 | 11.3 | | 11.5 | -11.0 | -49.5 | 25.5 |
| Gross margin | 53.1% | 48.8% | 37.9% | | 40.4% | -163.1% | 165.2% | 59.2% |
| Sales and marketing | 0.2 | 0.4 | 0.2 | | 0.3 | 0.4 | 0.8 | 1.2 |
| Research and development | 1.8 | 1.7 | 1.7 | | | | | |
| General and administrative | 1.1 | 1.0 | 1.0 | | 1.8 | 2.0 | 2.0 | |
| EBITA | 13.8 | 7.8 | -2.8 | | 6.8 | -16.3 | -55.4 | 12.3 |
| EBITA margin | 33.3% | 20.4% | -9.5% | | 24.0% | -240.9% | 184.9% | 28.4% |
| Amortization of intangibles | 0.9 | 1.0 | 1.0 | | 1.0 | 1.3 | 1.5 | 1.9 |
| EBIT | 12.9 | 6.9 | -3.8 | | 5.8 | -17.5 | -57.0 | 10.4 |
| EBIT margin | 31.1% | 17.9% | -12.7% | | 20.4% | -259.6% | 190.0% | 24.0% |
| Pre-tax income | 9.9 | 5.1 | -4.5 | | -11.9 | -49.1 | -59.3 | 0.0 |
| Income taxes | 3.6 | -37.5 | 0.0 | | -1.4 | 16.7 | -21.2 | 0.0 |
| Tax rate | 36.3% | | 0.0% | | 11.4% | | 35.8% | |
| Net income | 6.0 | 54.8 | -8.1 | | -12.6 | -67.7 | -39.9 | 0.0 |
| Net margin | 14.5% | 142.8% | -27.2% | | -44.2% | -1004.0% | 133.0% | 0.0% |
| |
| Diluted EPS | $0.92 | $11.08 | ($44.81) | | ($2.08) | ($11.20) | ($6.61) | |
| Shares outstanding (diluted) | 6.5 | 4.9 | 0.2 | | 6.1 | 6.0 | 6.0 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|